- Home
- Publications
- Publication Search
- Publication Details
Title
PPARα Agonist Oral Therapy in Diabetic Retinopathy
Authors
Keywords
-
Journal
Biomedicines
Volume 8, Issue 10, Pages 433
Publisher
MDPI AG
Online
2020-10-19
DOI
10.3390/biomedicines8100433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
- (2020) Shizuya Yamashita et al. Current Atherosclerosis Reports
- Elucidation of Molecular Mechanism of a Selective PPARα Modulator, Pemafibrate, through Combinational Approaches of X-ray Crystallography, Thermodynamic Analysis, and First-Principle Calculations
- (2020) Mayu Kawasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models
- (2020) Yohei Tomita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation
- (2020) Ricardo Raúl Robles-Rivera et al. Oxidative Medicine and Cellular Longevity
- Neurovascular Unit Dysfunction and Neurodegenerative Disorders
- (2020) Xing Yu et al. Frontiers in Neuroscience
- Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
- (2020) Yuji Nakano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARα activation directly upregulates thrombomodulin in the diabetic retina
- (2020) Akira Shiono et al. Scientific Reports
- Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy
- (2020) Yohei Tomita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroprotective effects of PPARα in retinopathy of type 1 diabetes
- (2019) Elizabeth A. Pearsall et al. PLoS One
- Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases
- (2019) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model
- (2019) Yohei Tomita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gene Expression Profiles Induced by a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα) Pemafibrate
- (2019) Yusuke Sasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα
- (2018) Yuta Yamamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Alpha-lipoic acid reduces retinal cell death in diabetic mice
- (2018) Yoon Sook Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice
- (2018) Zhongjie Fu et al. DIABETES
- Role of Inflammation in Diabetic Retinopathy
- (2018) Anne Rübsam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diabetic Retinopathy: Pathophysiology and Treatments
- (2018) Wei Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
- (2018) Hidenori Arai et al. Journal of Atherosclerosis and Thrombosis
- Treatment of acute ocular chemical burns
- (2018) Namrata Sharma et al. SURVEY OF OPHTHALMOLOGY
- The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
- (2018) Masaya Araki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
- (2018) Edgar D. Charles et al. Obesity
- Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
- (2017) Harald Staiger et al. ENDOCRINE REVIEWS
- The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice
- (2017) Tsuyoshi Goto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pathology associated with diabetic retinopathy
- (2017) Judith Lechner et al. VISION RESEARCH
- FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice
- (2017) Zhongjie Fu et al. Cell Reports
- The Role of Glycemic Control and Variability in Diabetic Retinopathy
- (2017) Irini P. Chatziralli Diabetes Therapy
- The Role of Glycemic Control and Variability in Diabetic Retinopathy
- (2017) Irini P. Chatziralli Diabetes Therapy
- Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn
- (2017) Takeshi Arima et al. Scientific Reports
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- Glia–neuron interactions in the mammalian retina
- (2016) Elena Vecino et al. PROGRESS IN RETINAL AND EYE RESEARCH
- The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study
- (2016) Adolfo Daniel Rodríguez-Carrizalez et al. REDOX REPORT
- Understanding Ubiquinone
- (2016) Ying Wang et al. TRENDS IN CELL BIOLOGY
- Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
- (2016) Cyrus Desouza Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver
- (2015) Sana Raza-Iqbal et al. Journal of Atherosclerosis and Thrombosis
- Neurovascular crosstalk between interneurons and capillaries is required for vision
- (2015) Yoshihiko Usui et al. JOURNAL OF CLINICAL INVESTIGATION
- Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia
- (2015) JIANFENG ZHAO et al. Experimental and Therapeutic Medicine
- Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
- (2015) Jan M. Keppel Hesselink et al. Journal of Ophthalmology
- Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina
- (2014) Lexi Ding et al. AMERICAN JOURNAL OF PATHOLOGY
- The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes
- (2014) Emily Y. Chew et al. OPHTHALMOLOGY
- Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
- (2013) Jean-Charles Fruchart Cardiovascular Diabetology
- The Role of Fibrate Treatment in Dyslipidemia: An Overview
- (2013) Niki Katsiki et al. CURRENT PHARMACEUTICAL DESIGN
- Pathogenic role of diabetes-induced PPAR- down-regulation in microvascular dysfunction
- (2013) Y. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular Adhesion Protein 1 in the Eye
- (2013) Wenting Luo et al. Journal of Ophthalmology
- Novel drugs and their targets in the potential treatment of diabetic retinopathy
- (2013) Mohammad Shamsul Ola MEDICAL SCIENCE MONITOR
- Optimal treatment of diabetic retinopathy
- (2013) Hans-Peter Hammes Therapeutic Advances in Endocrinology and Metabolism
- Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
- (2012) Ying Chen et al. DIABETES
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals
- (2012) R. Robinson et al. Disease Models & Mechanisms
- Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery
- (2012) Maria Rosaria Romano et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oxidative Stress in Preretinopathic Diabetes Subjects and Antioxidants
- (2011) Marcella Nebbioso et al. Diabetes Technology & Therapeutics
- A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways
- (2011) Kun-Ling Tsai et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema
- (2011) Christos Haritoglou et al. OPHTHALMOLOGICA
- PPARα: an emerging therapeutic target in diabetic microvascular damage
- (2010) Anne Hiukka et al. Nature Reviews Endocrinology
- Role of PPAR in Hepatic Carbohydrate Metabolism
- (2010) Annelies Peeters et al. PPAR Research
- Advances in the Medical Treatment of Diabetic Retinopathy
- (2009) R. Simo et al. DIABETES CARE
- Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes
- (2009) Kousuke Noda et al. EXPERIMENTAL EYE RESEARCH
- Localization of vascular adhesion protein-1 (VAP-1) in the human eye
- (2009) Lama Almulki et al. EXPERIMENTAL EYE RESEARCH
- Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?
- (2009) T M Curtis et al. EYE
- Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol
- (2008) Furong Wang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Vascular adhesion protein-1 blockade suppresses choroidal neovascularization
- (2008) Kousuke Noda et al. FASEB JOURNAL
- Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development
- (2008) Barbara D. Abbott REPRODUCTIVE TOXICOLOGY
- Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis
- (2007) Kousuke Noda et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started